Trial reportBMC anesthesiology2026
The effect of high-flow nasal cannula oxygen therapy on preventing hypoxemia during deep sedation extubation after laparoscopic surgery: a prospective randomized controlled trial.
Trial report in BMC anesthesiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundHigh-flow nasal cannula (HFNC) oxygen therapy has shown potential benefits in improving oxygenation in perioperative settings. However, its role in preventing early postoperative hypoxemia after extubation under deep sedation during laparoscopic surgery remains unclear.
methodsThis single-center randomized controlled trial enrolled 120 patients undergoing elective laparoscopic surgery. After extubation under deep sedation, patients were randomized to receive either HFNC or NC until discharge from the post-anesthesia care unit (PACU). Extubation under deep sedation was performed during emergence after discontinuation of anesthetic agents, when patients had regained spontaneous respiration but had not yet fully recovered consciousness, according to predefined clinical and bispectral index criteria.The primary outcome was hypoxemia, defined as peripheral oxygen saturation (SpO₂) < 90% for > 60 s between extubation and PACU discharge. Secondary outcomes included arterial partial pressure of oxygen/inspired oxygen fraction (PaO₂/FiO₂), arterial partial pressure of carbon dioxide (PaCO₂), heart rate, mean arterial pressure, and perioperative complications. Parameters were measured at six time points: before anesthesia (T0), immediately after extubation (T1), and at 5 (T2), 15 (T3), 30 (T4) minutes post-extubation, and at PACU discharge (T5).
resultsHypoxemia occurred in 24/60 (40%) NC patients and 12/60 (20%) HFNC patients (P = 0.028). Of those, mask-assisted positive pressure ventilation was needed in 11/24 NC and 2/12 HFNC patients (P = 0.026); jaw thrust was performed in 13/24 and 10/12, respectively. At T2 and T3, PaO₂/FiO₂ was higher (T2: 333.0 ± 34.6 vs. 286.3 ± 41.7; T3: 345.9 ± 34.5 vs. 303.2 ± 40.3 mmHg; both P < 0.001) and PaCO₂ lower (T2: 42.2 ± 4.2 vs. 48.8 ± 3.8; T3: 39.6 ± 3.7 vs. 45.3 ± 3.6 mmHg; both P < 0.001) in the HFNC group. No differences were found in PACU stay or other complications.
conclusionsHFNC oxygen therapy after extubation under deep sedation significantly reduces hypoxemia and improves early respiratory function versus NC, with comparable safety.
trial registrationChinese Clinical Trial Registry (ChiCTR2500107249, August 7, 2025).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.